Scarica l'app Stockscreener
164.40
0.29%
0.4713
Dopo l'orario di chiusura:
164.40
0.0044
+0.00%
Precedente Chiudi:
$163.92
Aprire:
$163.27
Volume 24 ore:
11,137
Relative Volume:
0.47
Capitalizzazione di mercato:
$3.19B
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+2.45%
1M Prestazione:
+7.62%
6M Prestazione:
-6.94%
1 anno Prestazione:
+10.93%
Intervallo 1D:
$163.14
$165.25
Intervallo di 1 settimana:
$158.84
$165.25
Portata 52W:
$141.38
$183.59
First Trust Nyse Arca Biotechnology Index Fund Stock (FBT) Company Profile
Nome
First Trust Nyse Arca Biotechnology Index Fund
Settore
Industria
Telefono
-
Indirizzo
-
Confronta FBT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FBT
First Trust Nyse Arca Biotechnology Index Fund
|
164.40 | 3.19B | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
277.22 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
563.51 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
566.17 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
220.85 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
485.93 | 124.43B | 0 | 0 | 0 | 0.00 |
First Trust Nyse Arca Biotechnology Index Fund Borsa (FBT) Ultime notizie
How to Take Advantage of moves in (FBT) - news.stocktradersdaily.com
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? - Yahoo Finance
Eli Lilly and Co (NYSE:LLY): Promising Breakthrough in Weight-Loss Treatments - Value The Markets
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - Yahoo Finance
Learn to Evaluate (FBT) using the Charts - news.stocktradersdaily.com
StockWatch: Trump Tariffs Take Biopharma on a Roller Coaster Ride - Genetic Engineering and Biotechnology News
StockWatch: Biopharma Funds Tumble with Wall Street as Industry Spared from Worst of Tariffs—for Now - Genetic Engineering and Biotechnology News
Monday's ETF Movers: FBT, XBI - Nasdaq
Where are the Opportunities in (FBT) - news.stocktradersdaily.com
Healthcare Sector Trying To Bounce Back - Seeking Alpha
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Nasdaq
Illumina Inc. (ILMN): Navigating Trade Restrictions Amid Rising Competition - Value The Markets
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
(FBT) Trading Advice - Stock Traders Daily
NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst - Benzinga
First Trust Nyse Arca Biotech Etf (FBT) - INDmoney
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds - br.ADVFN.com
(FBT) Investment Report - Stock Traders Daily
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - TradingView
How To Trade (FBT) - Stock Traders Daily
Shares Soar as GH Research Unveils Promising Drug Trial - Value the Markets
Should You Invest in the iShares Biotechnology ETF (IBB)? - TradingView
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - TradingView
(FBT) Trading Report - Stock Traders Daily
(FBT) Pivots Trading Plans and Risk Controls - Stock Traders Daily
LifeSci Capital Initiates Coverage of Biotech Exchange Traded Funds (ETFs) - AccessWire
When the Price of (FBT) Talks, People Listen - Stock Traders Daily
XBI: 3 Biotech ETFs for Diversified Innovation Exposure - StockNews.com
This Warren Buffett-Owned ETF Threatens SPY's Dominance - Inkl
Vanguard's S&P 500 ETF Hits $100 Billion Inflows In 2024: Is SPY's Crown At Risk? - Inkl
(FBT) Long Term Investment Analysis - Stock Traders Daily
Top 5 Life Science ETFs in 2024 - Investing News Network
Hedge funds were net buyers of financials, healthcare for week: Goldman Sachs - MSN
FBT Crowded With Sellers - Nasdaq
5 Biggest Biotechnology ETFs in 2024 - Nasdaq
(FBT) Technical Data - Stock Traders Daily
Analysts Forecast 26% Upside For FBT - Nasdaq
Is Semaglutide a Band-Aid, or a Solution? - Securities.io
Best Biotech ETFs to Watch Right Now - The Motley Fool
Training The Immune System To Attack Cancer With Probiotics - Securities.io
New mRNA Vaccine Could Tackle Antibiotic Resistant C. difficile Infections - Securities.io
Coffee crowned king of commodities - New Zealand Herald
Fighting Cancer with BioTech – Why mRNA Vaccines Are Such a Leap Forward - Securities.io
First Trust Nyse Arca Biotechnology Index Fund Azioni (FBT) Dati Finanziari
Non sono disponibili dati finanziari per First Trust Nyse Arca Biotechnology Index Fund (FBT). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.51%
0.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):